A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
Launched by UNIVERSITY OF CALIFORNIA, IRVINE · Dec 1, 2011
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying new imaging techniques that can help doctors understand how blood flows in the skin. The researchers want to see how well these non-invasive imaging tools work when they temporarily block blood flow using a pressure cuff. This is important for people with abnormal blood flow, as it can lead to various health issues.
To participate in this study, you need to be an adult aged 18 or older, and both men and women can join. Unfortunately, if you are younger than 18 or pregnant, you won't be eligible. If you decide to take part, you will help the researchers learn about these imaging methods, and your experience may contribute to future advancements in assessing skin blood flow. The trial is currently looking for participants, so there's an opportunity to get involved!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male and female adult 18 years and older
- Exclusion Criteria:
- • Younger than 18 years of age
- • Pregnant women
About University Of California, Irvine
The University of California, Irvine (UCI) is a leading research institution renowned for its commitment to advancing health and medical knowledge through innovative clinical trials. With a robust infrastructure for clinical research, UCI fosters interdisciplinary collaboration among its esteemed faculty and researchers, aiming to translate scientific discoveries into effective therapeutic solutions. The university prioritizes ethical standards and participant safety while addressing critical healthcare challenges across various fields, including cancer, neurology, and public health. UCI's dedication to excellence in research and education positions it as a pivotal contributor to the advancement of clinical science and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Irvine, California, United States
Irvine, California, United States
Patients applied
Trial Officials
Anthony Durkin, PhD
Principal Investigator
University of California, Irvine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials